Fentanyl makeover: Core structural redesign could lead to safer pain medications
littlexsparkee Thursday, February 26, 2026
Summary
Researchers at Scripps Research have developed a new molecule that can selectively bind to a protein involved in immune system regulation, potentially leading to new treatments for autoimmune diseases and cancer. The molecule, called JND-SP-741, was found to be effective in preclinical studies and could represent a promising therapeutic approach.
35
34
Summary
scripps.edu